Lovable is worth $13.3bn and its revenue is tripling. The interesting name on the cheque is the European Union. Lovable has raised $400m at a $13.3bn valuation. The Stockholm company lets people build software by describing it in ordinary language, and…
Joby Aviation has agreed to buy Resonant Sciences, a Dayton, Ohio radar and low-observability specialist, for about $500m, in the largest acquisition the electric air taxi company has made and the clearest signal yet of where it expects its near-term r…
Nvidia said on Monday it would partner with six of the largest names in private capital to finance AI infrastructure through vehicles worth more than $500 billion. Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR are all in. The compa…
Activist investor Anson Funds is pressing Lionsgate to redefine itself for the AI era or put itself up for sale, according to a July letter to the board reviewed by Semafor. The argument turns on how the market reads a film library. “The rise of genera…
River AI has raised $1.1bn, roughly four months after the company was incorporated. General Catalyst and AMP PBC led the round, with strategic investment from NVIDIA and AMD Ventures, and further money from Y Combinator and Temasek. The Palo Alto compa…
Nick Blair, a son of former UK prime minister Tony Blair, is trying to raise around $200m for a defence-tech startup that has not yet launched, reported by the Financial Times and described as ongoing and unconfirmed. The company, London-based Pyra, i…
HSBC Asset Management has taken a stake in Model ML, a London startup building what it calls an agentic operating system for financial services, and the deal says as much about where the industry now thinks the value in enterprise AI is settling as it …
Uniper, the German energy giant that Berlin rescued from collapse three years ago, is betting its next chapter on the server racks now reshaping Europe’s power market. The utility plans to invest around €5bn ($5.7bn) by 2030 in a strategy that pivots h…
A team of BioNTech alumni thinks cancer screening has been stuck in the past, and it has raised $25M to do something about it. Bios Life has emerged from stealth with a plan to replace one-off screening with continuous, AI-driven surveillance, and a da…
Hamburg biotech is taking an unusual shot at salmon farming’s most expensive pest, and it starts with an alpaca. AquaNab is developing tiny antibodies, derived from the animals and delivered through fish feed, to treat and prevent sea lice. The parasit…